1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALKEM LABORATORIES LTD.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523

Mid-range Performer
Download real time

4706.95 -42.45 (-0.89%)

26.91% Fall from 52W High

76,494 NSE+BSE Volume

NSE 13 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
12S
7W
1O
1T
56,278.6

Market Cap

High in industry
26.1

PE TTM

Below industry Median
0.7

PEG TTM

PEG TTM is less than 1
4.9

Price to Book

Above industry Median
0.5

Beta 1Year

Very Low volatility
Drug Launch
Alkem Labs launches generic empagliflozin in India with a market size of Rs 640 crore See details

Alkem Laboratories Ltd. - ALKEM - stock price prediction, stock forecast, target price, analyst ratings from 21 analysts

Alkem Laboratories Ltd. has a share price target of Rs 5385, revenue growth forecast of 3.0%, and profit growth estimate of 23.3% for FY25, based on top 21 analyst calls.

Forecaster Screeners